| Mrs Renee Michele Inkrott, MA, CCC/SLP | |
|
1700 E Sandusky St, Findlay, OH 45840-6463 | |
| (419) 422-8173 | |
| (419) 425-7055 |
| Full Name | Mrs Renee Michele Inkrott |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1700 E Sandusky St, Findlay, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275770281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP. 7473 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Renee Michele Inkrott, MA, CCC/SLP 1700 E Sandusky St, Findlay, OH 45840-6463 Ph: (419) 422-8173 | Mrs Renee Michele Inkrott, MA, CCC/SLP 1700 E Sandusky St, Findlay, OH 45840-6463 Ph: (419) 422-8173 |
News Archive
Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.
The U.S. energy portfolio changes over time. Scientific and technologic advances related to hydraulic fracturing have dramatically increased the supply of U.S. oil and gas; because of this, a methane economy - in which natural gas provides the leading share of primary energy consumption - is now a possible scenario for U.S. energy development. In a report released by the American Geosciences Institute, the social, political, technical and environmental components of a methane economy are identified.
A protein called ROBO1 may delay the progression of breast cancer, according to a paper published in The Journal of Cell Biology. The study, "Loss of miR-203 regulates cell shape and matrix adhesion through ROBO1/Rac/FAK in response to stiffness" by Lily Thao-Nhi Le and colleagues, identifies a signaling pathway that may protect breast cells from the tumorigenic effects of stiff extracellular matrices.
LGBT Health, a new peer-reviewed journal from Mary Ann Liebert, Inc., publishers, launching in fall 2013, presents a timely and in-depth perspective on several key controversies surrounding gender diagnoses.
› Verified 9 days ago
Sarah Distel, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 537 Cranberry E, Findlay, OH 45840 Phone: 219-575-1646 | |
Michelle Ellerbrock, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Hillcrest Ave # 4185, Findlay, OH 45840 Phone: 419-425-8317 | |
Mary C Estlack, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1725 Western Ave, Suite B, Findlay, OH 45840 Phone: 419-422-5526 Fax: 419-422-5562 | |
Glenn C Hoehne, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8580 Township Road 237, Findlay, OH 45840 Phone: 567-525-4460 | |
Jennifer Earl, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2019 Broad Ave, Findlay, OH 45840 Phone: 773-318-3163 | |
Ms. Cynthia Kay Arthur, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1100 Broad Ave, Findlay, OH 45840 Phone: 419-425-8310 | |
Barbara A Kampf, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1725 Western Ave, Ste B, Findlay, OH 45840 Phone: 419-422-5526 |